7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 
      
                           
      cash flows from operating activities:
                           
      net income
    2,647,000 24,642,000 45,594,000 51,697,000 43,824,000 42,631,000 53,993,000 22,630,000 -3,969,000 -24,086,000 -29,034,000 -25,985,000 -4,879,000 9,738,000 7,169,000 -5,484,000 -9,362,000 -13,068,000 -16,160,000 -15,150,000 284,000 6,479,000 891,000 
      adjustments to reconcile net income to net cash from operating activities:
                           
      depreciation and amortization
    12,822,000 11,255,000 15,706,000 13,892,000 12,440,000 12,895,000 12,031,000 11,609,000 10,550,000 10,275,000 9,804,000 9,313,000 8,118,000 7,394,000 6,876,000 6,197,000 5,463,000 4,402,000 4,083,000 3,972,000 3,707,000 3,688,000 3,594,000 
      accretion of discounts on marketable securities
    -10,927,000 -10,370,000  -12,844,000 -12,569,000 -14,126,000                  
      amortization of issuance costs
    1,691,000 1,819,000 1,089,000 912,000 910,000 850,000  848,000 846,000 845,000  843,000 842,000 840,000  838,000 837,000 835,000      
      amortization of deferred contract costs
    15,977,000 14,853,000 14,279,000 13,474,000 12,450,000 11,844,000 10,984,000 10,227,000 9,348,000 8,648,000 8,062,000 7,361,000 6,558,000 6,022,000 5,309,000 4,704,000 4,074,000 3,779,000 3,099,000 2,721,000 2,442,000 2,185,000 1,712,000 
      stock-based compensation, net of amounts capitalized
    180,462,000 164,265,000 158,461,000 142,190,000 134,652,000 135,033,000 128,121,000 123,114,000 118,337,000 112,728,000 112,509,000 101,362,000 82,399,000 66,884,000 56,366,000 43,995,000 34,515,000 28,861,000 24,764,000 20,716,000 16,834,000 12,060,000 9,018,000 
      non-cash lease expense
    9,001,000 8,389,000 7,002,000 6,670,000 6,781,000 6,810,000 7,050,000 7,136,000 6,252,000 5,944,000 6,180,000 5,550,000 5,275,000 4,411,000 4,596,000 4,544,000 4,049,000 4,012,000 4,056,000 3,453,000 3,325,000 3,226,000  
      allowance for credit losses on accounts receivable
    3,895,000 4,520,000 4,473,000 3,800,000 3,842,000 2,732,000 2,836,000 2,786,000 2,579,000 3,732,000 1,286,000 1,998,000 1,133,000 798,000 1,085,000 699,000 502,000 25,000 627,000     
      loss on disposal of property and equipment
      1,308,000 9,000 300,000 43,000 287,000 -2,000 333,000 88,000 510,000 3,000 326,000 823,000 16,000 102,000 153,000 3,000 6,000 -4,000 6,000 2,000  
      changes in operating assets and liabilities:
                           
      accounts receivable
    -115,899,000 104,227,000 -116,327,000 42,428,000 -86,076,000 55,490,000 -111,467,000 -70,333,000 31,366,000 28,773,000 -51,963,000 -45,638,000 -30,781,000 -7,319,000 -45,232,000 -36,972,000 -34,131,000 9,223,000 -42,995,000 2,431,000 -16,568,000 -7,116,000 -15,286,000 
      deferred contract costs
    -24,301,000 -21,519,000 -24,725,000 -19,153,000 -19,534,000 -12,636,000 -26,869,000 -14,994,000 -15,868,000 -11,750,000 -16,427,000 -13,202,000 -13,303,000 -8,166,000 -15,165,000 -10,909,000 -9,990,000 -6,711,000 -9,276,000 -4,567,000 -6,618,000 -4,619,000 -9,252,000 
      prepaid expenses and other current assets
    11,343,000 -10,263,000 -16,581,000 -1,630,000 5,632,000 -14,075,000 -3,194,000 6,509,000 -1,013,000 -15,810,000 4,715,000 1,349,000 -4,238,000 -8,391,000 204,000 1,596,000 3,461,000 -5,998,000 2,418,000 -340,000 -5,077,000 -1,404,000 -570,000 
      other assets
    -1,821,000 -1,217,000 -4,639,000 1,465,000 -443,000 2,614,000 -225,000 -998,000 2,077,000 164,000 -3,259,000 -168,000 -947,000 -805,000 -783,000 -912,000 -1,504,000 572,000 1,573,000 310,000 -1,834,000 919,000 -6,000 
      accounts payable
    96,352,000 -10,712,000 17,034,000 -22,994,000 48,692,000 -17,122,000 505,000 32,371,000 6,352,000 18,545,000 -3,769,000 -20,696,000 30,803,000 -7,624,000 -9,354,000 5,060,000 16,598,000 -9,226,000 133,000 3,714,000 4,083,000 -1,391,000 -1,729,000 
      accrued expenses and other liabilities
    -3,250,000 5,648,000 4,083,000 10,147,000 -8,423,000 -7,433,000 27,753,000 -24,153,000 -16,009,000 -28,080,000 10,228,000 31,660,000 -1,399,000 -2,911,000 18,044,000 11,918,000 -2,374,000 9,682,000 -2,914,000 5,236,000 -377,000 2,025,000 8,366,000 
      deferred revenue
    21,086,000 -13,851,000 170,265,000 -1,382,000 21,946,000 6,720,000 132,937,000 58,998,000 10,073,000 28,966,000 67,246,000 29,348,000 -9,685,000 81,735,000 81,416,000 38,287,000 35,578,000 21,000,000 41,824,000 1,177,000 19,903,000 6,884,000 16,694,000 
      net cash from operating activities
    200,055,000 271,541,000 265,228,000 228,681,000 164,424,000 212,270,000 220,226,000 152,783,000 153,158,000 133,787,000 114,441,000 83,618,000 72,960,000 147,388,000 115,793,000 67,379,000 51,723,000 51,650,000 23,828,000 36,270,000 24,738,000 24,255,000 17,430,000 
      capex
    -34,702,000 -27,150,000 -24,256,000 -25,077,000 -20,644,000 -25,523,000 -18,936,000 -14,594,000 -11,426,000 -17,450,000 -18,090,000 -16,518,000 -12,794,000 -17,487,000 -9,110,000 -10,296,000 -9,438,000 -7,181,000 -7,176,000 -7,629,000 -6,135,000 -4,943,000 -6,572,000 
      free cash flows
    165,353,000 244,391,000 240,972,000 203,604,000 143,780,000 186,747,000 201,290,000 138,189,000 141,732,000 116,337,000 96,351,000 67,100,000 60,166,000 129,901,000 106,683,000 57,083,000 42,285,000 44,469,000 16,652,000 28,641,000 18,603,000 19,312,000 10,858,000 
      cash flows from investing activities:
                           
      purchases of marketable securities
    -751,477,000 -970,302,000 -507,309,000 -905,632,000 -602,950,000 -637,351,000 -546,156,000 -621,523,000 -632,547,000 -757,787,000 -345,985,000 -348,947,000 -389,079,000 -329,706,000 -228,107,000 -406,429,000 -340,652,000 -150,331,000 -317,499,000 -273,550,000 -776,031,000 -427,482,000  
      maturities of marketable securities
    697,172,000 555,938,000 428,445,000 624,402,000 564,319,000 401,666,000 396,582,000 449,658,000 520,669,000 497,648,000 280,531,000 340,439,000 317,051,000 199,703,000 110,868,000 365,486,000 316,972,000 253,234,000 238,054,000 146,646,000 119,234,000 2,620,000  
      proceeds from sale of marketable securities
    13,212,000 -76,000 233,000 -40,000   602,000 -240,000 15,292,000 21,341,000 84,000 -1,000 2,007,000 6,617,000 19,417,000 35,218,000 6,497,000 77,930,000     
      purchases of property and equipment
    -15,152,000 -8,748,000 -7,761,000 -8,385,000 -4,415,000 -14,158,000 -10,395,000 -6,113,000 -2,339,000 -8,739,000 -10,054,000 -9,706,000 -5,987,000 -9,514,000 -2,405,000 -3,324,000 -3,229,000 -998,000 -1,079,000 -1,412,000 -1,398,000 -1,526,000 -3,502,000 
      capitalized software development costs
    -19,550,000 -18,402,000 -16,495,000 -16,692,000 -16,229,000 -11,365,000 -8,541,000 -8,481,000 -9,087,000 -8,711,000 -8,036,000 -6,812,000 -6,807,000 -7,973,000 -6,705,000 -6,972,000 -6,209,000 -6,183,000 -6,097,000 -6,217,000 -4,737,000 -3,417,000 -3,070,000 
      cash paid for acquisition of businesses; net of cash acquired
    -115,272,000 -1,818,000 -6,477,000 -210,000   -6,129,000 -4,344,000   -5,576,000 -736,000 -34,695,000 -4,871,000 -26,303,000 146,000 -188,839,000 -11,509,000    
      net cash from investing activities
    -191,067,000 -443,408,000 -109,364,000 -306,557,000 -59,711,000 -261,208,000 -174,037,000 -191,043,000 -110,037,000 -256,248,000 -89,120,000 -25,678,000 -119,518,000 -150,354,000 -146,035,000 -31,676,000 -186,739,000 90,710,000 -8,691,000 -48,833,000 -665,295,000 -429,805,000 -185,349,000 
      cash flows from financing activities:
                           
      proceeds from exercise of stock options
    1,685,000 1,673,000 2,243,000 1,257,000 1,753,000 2,191,000 3,505,000 9,870,000 5,436,000 2,098,000 1,734,000 1,816,000 2,206,000 4,245,000 4,256,000 4,489,000 2,887,000 3,275,000 3,631,000 5,119,000 4,422,000 2,813,000 593,000 
      proceeds from issuance of common stock under the employee stock purchase plan
      21,179,000   17,384,000   12,468,000   10,484,000   7,490,000    
      proceeds from issuance of 2029 convertible senior notes, net of issuance costs
                           
      repayments of 2025 convertible senior notes
    -635,527,000 -20,000                      
      net cash from financing activities
    -605,454,000 1,653,000 759,424,000 1,233,000 24,235,000 2,191,000 20,889,000 9,870,000 25,422,000 2,098,000 14,202,000 1,816,000 15,763,000 4,242,000 14,740,000 4,489,000 12,681,000 3,030,000 11,058,000 4,527,000 652,031,000 2,660,000 -1,749,000 
      effect of exchange rate changes on cash and cash equivalents
    5,642,000 3,085,000                      
      net increase in cash and cash equivalents
                           
      cash and cash equivalents—beginning of period
    1,246,983,000                      
      cash and cash equivalents—end of period
    -590,824,000 1,079,854,000                      
      supplemental disclosures of cash flow information:
                           
      cash paid for income taxes
    7,648,000 3,658,000 5,182,000 989,000 10,175,000 4,647,000 2,342,000 3,486,000 7,655,000 3,022,000 513,000 696,000 47,000 339,000 547,000 396,000 216,000 327,000 224,000 44,000 108,000 34,000 46,000 
      supplemental disclosure of non-cash investing and financing activities:
                           
      accrued property and equipment purchases
    3,618,000 4,542,000 2,179,000 -1,097,000 3,027,000 813,000 1,899,000 4,873,000 -30,000 304,000 -690,000 584,000 -1,916,000 2,994,000 496,000 336,000 701,000 213,000 -81,000 -499,000 204,000 610,000 -1,259,000 
      stock-based compensation included in capitalized software development costs
    5,957,000 5,662,000 1,871,000 4,375,000 4,260,000 2,646,000 2,289,000 3,071,000 4,010,000 4,227,000 4,093,000 3,920,000 3,334,000 3,506,000 2,898,000 2,550,000 2,059,000 2,153,000 1,883,000 1,220,000 198,000 103,000 64,000 
      issuance of restricted shares of common stock for the acquisition of businesses
              6,411,000   6,219,000 31,329,000 20,172,000    
      acquisition holdback
    16,022,000 50,000       2,650,000   4,360,000 1,195,000    
      (gain) loss on disposal of property and equipment
     -145,000                      
      net decrease in cash and cash equivalents
     -167,129,000                      
      amortization of (discounts) premiums on marketable securities
          -15,365,000 -12,965,000 -8,096,000 -5,195,000              
      net income on conversion inducement and capped call settlement
                           
      proceeds from settlement of capped calls related to 2025 convertible senior notes
                           
      purchase of capped calls related to 2029 convertible senior notes
                           
      effect of exchange rate changes on cash, cash equivalents and restricted cash
      -5,723,000 3,098,000 -203,000 -1,374,000 1,952,000 -1,605,000 213,000 623,000 4,931,000 -3,995,000 -2,242,000 -629,000 -573,000 -758,000 120,000 -782,000 386,000 506,000 28,000 -141,000  
      net increase in cash, cash equivalents and restricted cash
      909,565,000 -73,545,000   69,030,000   -119,740,000 44,454,000 55,761,000 -33,037,000 647,000 -16,075,000 39,434,000 -122,215,000 144,608,000 26,581,000 -7,530,000 11,502,000 -403,031,000 -169,738,000 
      cash, cash equivalents and restricted cash—beginning of period
      330,339,000 342,288,000 274,463,000 228,711,000 601,189,000 
      cash, cash equivalents and restricted cash—end of period
      909,565,000 -73,545,000 128,745,000 282,218,000 69,030,000 -29,995,000 68,756,000 222,548,000  55,761,000 -33,037,000 275,110,000  39,434,000 -122,215,000 373,319,000      
      vesting of early exercised options
              33,000 33,000 33,000 207,000 293,000 294,000 295,000 294,000 294,000 393,000 
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts show in the statements of cash flows above:
                           
      cash and cash equivalents
      909,565,000 -73,545,000 128,745,000 282,218,000 69,030,000 -29,995,000 68,756,000 222,548,000 44,170,000 55,956,000 -32,827,000 271,686,000 -15,993,000 39,524,000 -122,264,000 369,706,000 26,404,000 -7,679,000 11,852,000 194,350,000 -163,648,000 
      restricted cash
              284,000 -195,000 -210,000 3,424,000          
      total cash, cash equivalents and restricted cash
          69,030,000 -29,995,000 68,756,000 222,548,000 44,454,000 55,761,000 -33,037,000 275,110,000 -16,075,000 39,434,000 -122,215,000 373,319,000 26,581,000 -7,530,000 11,502,000 198,158,000 -169,738,000 
      repayments of convertible senior notes
       -24,000       -3,000          
      reconciliation of cash and cash equivalents within the condensed consolidated balance sheets to the amounts shown in the statements of cash flows above:
                           
      total cash and cash equivalents
       -73,545,000 128,745,000 282,218,000                  
      net decrease in cash, cash equivalents and restricted cash
         -48,121,000                  
      amortization of debt discount and issuance costs
                      8,181,000 8,062,000    
      employee payroll taxes paid related to net share settlement under the employee stock purchase plan
                  -245,000 -63,000 -118,000    
      reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the statements of cash flows above:
                           
      amortization of discounts or premiums on marketable securities
              -2,491,000 520,000 2,738,000 3,959,000 4,407,000 3,716,000 3,854,000 4,259,000 4,409,000 3,884,000 1,216,000 244,000  
      proceeds from initial public offering, net of underwriting discounts and commissions and other offering costs
                          -2,342,000 
      proceeds from issuance of convertible senior notes, net of issuance costs
                      -474,000    
      purchase of capped call related to convertible senior notes
                         
      cash, cash equivalents and restricted cash —end of period
                      26,581,000 -7,530,000 11,502,000 198,158,000 -169,738,000 
      costs related to initial public offering included in accounts payable and accrued liabilities
                         268,000 -2,298,000 
      restricted cash – including amounts in prepaid expense and other current assets and other assets
                    49,000 3,613,000 177,000 149,000 -350,000 3,808,000 -6,090,000 
      initial public offering costs
                        -268,000 -153,000  
      convertible senior notes issuance costs included in accounts payable and accrued liabilities
                           
      deferred tax liability related to convertible senior notes issuance
                           
      deferred tax liability related to unrealized gain on marketable securities
                           
      proceeds from initial public offering, net of underwriting discounts and commissions and other offering cost
                           
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above:
                           
      benefit from accounts receivable allowance
                        928,000 1,073,000 360,000 
      acquisition of intangible assets through issuance of common stock
                           
      noncash lease expense
                           
      gain on disposal of property and equipment
                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.